Mehmet Yalim

The Comparison of Porous Titanium Granule and Xenograft in the Surgical Treatment of Peri‐Implantitis: A Prospective Clinical Study

BACKGROUND Regarding the current approach, there is no evidence to show which treatment technique is the most accurate and useful in peri-implant defects. PURPOSE The aim of this study is comparing the effect of porous titanium granule (PTG) with rotary titanium brush and the use of xenograft and collagen membrane in the treatment of intra-bony peri-implant defects. MATERIALS AND METHODS Twenty-two patients, suffering peri-implantitis defects were included this study. Patients were divided into two groups: The PTG group used rotary titanium brush, PTG, and platelet rich fibrin (PRF) membrane. The XGF group used xenograft bone substitute, collagen membrane, and PRF membrane. Clinical measurements and cone beam computed tomography per region were recorded as baseline and sixth month after surgery. RESULTS The mean CAL values were improved from 5.29 ± 1.06 to 3.59 ± 0.88 mm in PTG group, while in XGF group; these values were improved from 4.77 ± 1.05 to 3.30 ± 0.58 mm. Radiographic bone filling values displayed a statistically significant difference between of groups. In PTG groups, these radiological values increased more than the XGF group. CONCLUSIONS PTG may be more appropriate for peri-implantitis surgery than xenograft due to inert structure and comfortable use of PTG to provide mechanical support for enlarging the surface area of the implant.

Effect of Titanium-prepared Platelet-rich Fibrin Treatment on the Angiogenic Biomarkers in Gingival Crevicular Fluid in Infrabony Defects of Patients with Chronic Periodontitis: A Randomized Controlled Clinical Trial

Aim: The aim of this double-blinded, randomized, controlled clinical study was to investigate the effect of titanium-prepared platelet-rich fibrin (T-PRF) treatment on the angiogenic biomarkers in gingival crevicular fluid (GCF) in infrabony defects of patients with chronic periodontitis. Materials and Methods: Twenty five systemically healthy participants who complied with inclusion criteria with periodontal infrabony defects were recruited. In each patient, the infrabony defect of one side of arch was designated as control group (allograft), whereas the infrabony defect on the contralateral side of same arch was designated as test group (allograft + T-PRF). The therapy methods (test or control) were randomly decided. GCF samples were collected at baseline (presurgery) and then the 3rd, 7th, 14th, and 30th days after surgery. Platelet-derived growth factor (PDGF)-BB, vascular endothelial growth factor (VEGF)-A, fibroblast growth factor (FGF)-2, anjiogenin (ANG), angiostatin (ANT) in the GCF samples were measured using human enzyme-linked immunosorbent assay kits. Results: In both groups, total amounts of PDGF-BB, VEGF-A, FGF-2, ANG, and ANT peaked in the GCF samples obtained at the early postoperative day (day 3) and decreased over time in the samples obtained at the 7th, 14th, and 30th days postsurgery. There were no significant differences between groups for the total amounts of PDGF-BB, VEGF-A, FGF-2, ANG, and ANT at all evaluation periods. Conclusion: Application of T-PRF combined with allograft in infrabony defects of patients with chronic periodontitis had no significant effects on angiogenic biomarkers in GCF.